Comparison of the Effects of Trendelenburg Position and Passive Leg Lift on Hemodynamics in Abdominal Surgery Patients

How to maintain the stability of circulation during anesthesia has always been a concern of clinicians, including shorting the preoperative fasting time under the condition of full preoperative preparation, and giving appropriate amount of nutrient solution in combination with the patient's situation 2~4 h before surgery to reduce the blood volume insufficiency of patients before general anesthesia induction, vasoactive drugs, etc. Among them, passive leg lifting experiment is widely recognized in the world. Although passive leg lifting has many advantages, it still has some limitations in the operation process. This study tried to find the corresponding head low and foot high Angle corresponding to the same hemodynamic changes caused by passive leg lifting.

Study Overview

Status

Recruiting

Detailed Description

For low head and high feet, studies have shown that 20° can reduce the incidence of hypotension during the induction period of general anesthesia in patients undergoing gastrectomy and has therapeutic effect on it, as well as reduce the use of vasoactive drugs during the induction period of general anesthesia. There were no perioperative complications.

The passive leg lift test can be repeated and does not overload the patient with fluid. However, there is no relevant research on the relationship between the two, which is exactly the innovation of this topic.

Study Type

Interventional

Enrollment (Anticipated)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Liaoning
      • Dalian, Liaoning, China
        • Recruiting
        • The Second Affiliated Hospital of Dalian Medical University
        • Contact:
          • dan hua, master
          • Phone Number: 17709862909
        • Contact:
          • yanan pu, master

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18~75 years old
  • Good image of TTE can be obtained
  • Sedative mechanical ventilation (Vt 8~10ml/kg)
  • Circulation was relatively stable before the experiment began
  • There is no contraindication to rehydration

Exclusion Criteria:

  • TTE acquisition is not ideal
  • Patients did not agree to participate in the experiment
  • Diseases of the central nervous system,patients with increased intracranial pressure
  • Arrhythmia patients;
  • Patients with increased intra-abdominal pressure;
  • Bedridden patients;
  • Patients with venous thrombosis of lower limbs;
  • Patients with venous foreign body of lower limbs;
  • Patients with circulatory instability;
  • Patients with obstructive shock;
  • Patients with moderate or above heart valve reflux

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Trendeleburg -5 degree group,-10 degree group,-15 degree group
Norepinephrine was continuously pumped at 0.5ug/kg/min
Use a -5 or -10 or -15 degree trendelenburg position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PPV(pulse pressure variation)
Time Frame: T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
Change from PPV at T1to T6
T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
VTI(velocity time integral)
Time Frame: T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
Change from VTI at T1 to T6
T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SBP(Systolic Blood Pressure)
Time Frame: T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
The variation tendency of T1 to T6
T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
MAP(Mean Artery Pressure)
Time Frame: T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
The variation tendency of T1 to T6
T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
HR HR(Heart Rate)
Time Frame: T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion
The variation tendency of T1 to T6
T1:A supine position with a 10° upward bed angulation;T2: After passive leg lift;T3:The same position with T1;T4:After trendelenburg position;T5:The same position with T1;T6:After fluid infusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dan Hua, Master, Dalian Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Anticipated)

June 30, 2022

Study Completion (Anticipated)

July 15, 2022

Study Registration Dates

First Submitted

June 20, 2021

First Submitted That Met QC Criteria

July 12, 2021

First Posted (Actual)

July 21, 2021

Study Record Updates

Last Update Posted (Actual)

October 20, 2021

Last Update Submitted That Met QC Criteria

October 15, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • yangmi

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on The Angle of Trendelenburg

Clinical Trials on Trendeleburg -5 degree,-10 degree,-15 degree

3
Subscribe